Development and Optimization of an ELISA to Quantitate C3(H(2)O) as a Marker of Human Disease

Discovery of a C3(H(2)O) uptake pathway has led to renewed interest in this alternative pathway triggering form of C3 in human biospecimens. Previously, a quantifiable method to measure C3(H(2)O), not confounded by other complement activation products, was unavailable. Herein, we describe a sensitiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Elvington, Michelle, Liszewski, M. Kathryn, Liszewski, Alexis R., Kulkarni, Hrishikesh S., Hachem, Ramsey R., Mohanakumar, Thalachallour, Kim, Alfred H. J., Atkinson, John P.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6458276/
https://ncbi.nlm.nih.gov/pubmed/31019515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00703
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados